Literature DB >> 8960754

Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family.

A Kishore1, Z K Wszolek, B J Snow, R de la Fuente-Fernandez, F Arwert, M Wijker, M Schulzer, D B Calne, F J Vingerhoets.   

Abstract

Pallido-ponto-nigral degeneration (PPND) is a dominantly inherited disorder with parkinsonism. We performed PET with [18F]fluorodopa (FD) and, later, gene testing in 12 asymptomatic relatives at risk from a family with PPND and compared the striatal FD uptake constant (Ki) in them with 4 symptomatic individuals and 10 normal control subjects. Four relatives with positive linkage had a significantly reduced Ki from the normal control subjects but to a lesser degree than the symptomatic patients. The mean Ki in the relatives with negative linkage (n = 8) did not differ from normal control subjects. In conclusion, we identified reduced dopaminergic function in asymptomatic relatives with positive genetic linkage from the PPND family. Most of the reduction in this disorder occurs in the fifth decade, when the disease manifests clinically.

Entities:  

Mesh:

Year:  1996        PMID: 8960754     DOI: 10.1212/wnl.47.6.1588

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Pathophysiology of manganese-associated neurotoxicity.

Authors:  Brad A Racette; Michael Aschner; Tomas R Guilarte; Ulrike Dydak; Susan R Criswell; Wei Zheng
Journal:  Neurotoxicology       Date:  2011-12-21       Impact factor: 4.294

2.  Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD.

Authors:  J L Whitwell; K A Josephs; R Avula; N Tosakulwong; S D Weigand; M L Senjem; P Vemuri; D T Jones; J L Gunter; M Baker; Z K Wszolek; D S Knopman; R Rademakers; R C Petersen; B F Boeve; C R Jack
Journal:  Neurology       Date:  2011-08-17       Impact factor: 9.910

3.  EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.

Authors:  Silvia Morbelli; Giuseppe Esposito; Javier Arbizu; Henryk Barthel; Ronald Boellaard; Nico I Bohnen; David J Brooks; Jacques Darcourt; John C Dickson; David Douglas; Alexander Drzezga; Jacob Dubroff; Ozgul Ekmekcioglu; Valentina Garibotto; Peter Herscovitch; Phillip Kuo; Adriaan Lammertsma; Sabina Pappata; Iván Peñuelas; John Seibyl; Franck Semah; Livia Tossici-Bolt; Elsmarieke Van de Giessen; Koen Van Laere; Andrea Varrone; Michele Wanner; George Zubal; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-09       Impact factor: 9.236

4.  Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation.

Authors:  Haruka Takeshige; Sachiko Nakayama; Kenya Nishioka; Yuanzhe Li; Yumiko Motoi; Nobutaka Hattori
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.